Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine.
about
G protein betagamma subunits regulate cell adhesion through Rap1a and its effector RadilThe outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyTrisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cellsTotal proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.Integrin-epigenetics: a system with imperative impact on cancer.Rho and Rap guanosine triphosphatase signaling in B cells and chronic lymphocytic leukemia.The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas.Role of LFA-1 and ICAM-1 in Cancer.In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection
P2860
Q24645022-240B30A3-2B14-40F5-B61B-7DC014B1F015Q26865760-1E1A3528-FD9E-43BB-BBA7-61F568B106DCQ33814458-E1ABBF12-878A-4C0D-81AE-A52D06CC62AEQ35110849-9C0B750E-B9F2-40AD-904B-11845082F6CAQ35325738-009C1F04-B5A0-44AF-A8DE-EBCBC9F8EC2CQ36010202-9D485AD4-7355-435F-9FE9-EE95A6A500B4Q36311118-231573E2-CC7D-4300-9E4C-E1B23567A06DQ37565511-8381D0B4-F759-4103-A28E-21449C8EAF12Q37967439-C35CB53C-9EE1-40BC-A3D8-DB2C5D7EC0A5Q38163044-172809C8-988F-4A5D-A619-48AF623F7A62Q39786234-BF4BAC89-04DB-4B55-A015-00A4717E394DQ47106562-649A8800-B60A-48B6-9A5B-53A0F0208134Q48090885-20BC999A-59AA-448E-AD99-A99FECF4A389Q53336736-ED0F6702-B95A-4EF5-8E6A-176B7CF744E5Q58042009-5A3D9908-C4B2-4A9D-A284-FC5E59DF77CE
P2860
Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@en
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@nl
type
label
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@en
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@nl
prefLabel
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@en
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@nl
P2093
P1433
P1476
Cell motility in chronic lymph ...... beta2 activation by chemokine.
@en
P2093
Andrea Linford
John C Cawley
Kathleen J Till
Mirko Zuzel
Robert J Harris
P304
P356
10.1158/0008-5472.CAN-08-1758
P407
P577
2008-10-01T00:00:00Z